0001475030-12-000001.txt : 20120322 0001475030-12-000001.hdr.sgml : 20120322 20120322121938 ACCESSION NUMBER: 0001475030-12-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120322 DATE AS OF CHANGE: 20120322 EFFECTIVENESS DATE: 20120322 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tarsa Therapeutics, Inc. CENTRAL INDEX KEY: 0001475030 IRS NUMBER: 264828302 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-175388 FILM NUMBER: 12708706 BUSINESS ADDRESS: STREET 1: 8 PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 267-273-7940 MAIL ADDRESS: STREET 1: 8 PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19103 D 1 primary_doc.xml X0704 D LIVE 0001475030 Tarsa Therapeutics, Inc. 8 PENN CENTER 1628 JOHN F. KENNEDY BLVD, STE. 1400 PHILADELPHIA PA PENNSYLVANIA 19103-2124 267-273-7940 DELAWARE None None Corporation true 2009 David Brand c/o Tarsa Therapeutics, Inc. 8 Penn Center, 1628 JFK Blvd., Ste. 1400 Philadelphia PA PENNSYLVANIA 19103-2124 Executive Officer Director Eric Bednarski c/o Tarsa Therapeutics, Inc. 8 Penn Center, 1628 JFK Blvd., Ste. 1400 Philadelphia PA PENNSYLVANIA 19103-2124 Director Martin Edwards c/o Tarsa Therapeutics, Inc. 8 Penn Center, 1628 JFK Blvd., Ste. 1400 Philadelphia PA PENNSYLVANIA 19103-2124 Director Ashleigh Palmer c/o Tarsa Therapeutics, Inc. 8 Penn Center, 1628 JFK Blvd., Ste. 1400 Philadelphia PA PENNSYLVANIA 19103-2124 Director Matthew Rieke c/o Tarsa Therapeutics, Inc. 8 Penn Center, 1628 JFK Blvd., Ste. 1400 Philadelphia PA PENNSYLVANIA 19103-2124 Director James Tananbaum c/o Tarsa Therapeutics, Inc. 8 Penn Center, 1628 JFK Blvd., Ste. 1400 Philadelphia PA PENNSYLVANIA 19103-2124 Director Gregory Lumpkin c/o Tarsa Therapeutics, Inc. 8 Penn Center, 1628 JFK Blvd., Ste. 1400 Philadelphia PA PENNSYLVANIA 19103-2124 Executive Officer Lewis Geffen c/o Tarsa Therapeutics, Inc. 8 Penn Center, 1628 JFK Blvd., Ste. 1400 Philadelphia PA PENNSYLVANIA 19103-2124 Executive Officer Biotechnology Decline to Disclose 06 false 2012-03-13 false true true false 0 28000000 13767857 14232143 false 5 0 0 0 true false Tarsa Therapeutics, Inc. /s/ David Brand David Brand President and Chief Executive Officer 2012-03-22